Joint Corp Q2 net loss $3.6M ($0.24/sh); revenue $30.3M up 3% YoY; guidance reaffirmed

JOINT Corp

2024-Q2 EPS reported -$0.18 revenue$59,982,727

Net loss $3.6M ($0.24 loss per share) vs net loss $320K ($0.02 loss) in Q2 2023.
Revenue $30.3M +3% YoY; system-wide sales $129.6M +8%; comp sales +2%.
Adjusted EBITDA $2.1M vs $3.2M; includes $1.5M litigation expense and $1.4M impairment.
Sold 7 franchise licenses (vs 21); total clinics 960; over 10 refranchise LOIs in progress.
2024 guidance reiterated: system-wide sales $530-545M, mid-single digit comps, 60-75 new clinics.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.